The Food and Drug Administration's Office of Orphan Products Development: incentives, grants, and special designations speed therapies for orphan diseases.
Haffner
Marlene E
ME
The FDA Office of Orphan Products Development and Public Health Service, USA.
D005380:Financing, Government / Q000331:legislation & jurisprudence*; D006801:Humans; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence*; D035583:Rare Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*